TE_13845
Basic information Differential Expression Stage analysis Survival analysis Correlation analysisTE family | L1HS_5end |
---|---|
TE superfamily | L1 |
TE class | LINE |
Gene | LINC01611, - |
Class | Chimeric, Intergenic |
Coding | Non-coding |
Tumor-specific score | 194.99 |
Counts of samples | TCGA_tumor:691; TCGA_normal:3; GTEx:0 |
TSS | chr6(-):84626817 |
Transcript isoforms
Transcript_ID | Gene | Class | Coding | ORF | Position |
---|---|---|---|---|---|
teRNA_13845.1 | LINC01611 | Chimeric | Non-coding | Non-coding | chr6(-):84421222,84421242,84444387,84444451,84556019,84556154,84626325,84626818 |
teRNA_13845.2 | - | Intergenic | Non-coding | Non-coding | chr6(-):84567793,84567813,84626325,84626818 |
teRNA_13845.3 | - | Intergenic | Non-coding | Non-coding | chr6(-):84624263,84624283,84626325,84626818 |
teRNA_13845.4 | LINC01611 | Chimeric | Non-coding | Non-coding | chr6(-):84421222,84421242,84444387,84444451,84556019,84556154,84624193,84624283,84626325,84626818 |
teRNA_13845.5 | - | Intergenic | Non-coding | Non-coding | chr6(-):84608130,84608150,84626325,84626818 |
teRNA_13845.6 | LINC01611 | Chimeric | Non-coding | Non-coding | chr6(-):84421222,84421242,84444387,84444451,84626325,84626818 |
teRNA_13845.7 | LINC01611 | Chimeric | Non-coding | Non-coding | chr6(-):84421222,84421242,84444387,84444451,84470791,84470904,84626325,84626818 |
teRNA_13845.8 | LINC01611 | Chimeric | Non-coding | Non-coding | chr6(-):84421222,84421242,84444387,84444451,84458175,84458253,84626325,84626818 |
teRNA_13845.9 | - | Intergenic | Non-coding | Non-coding | chr6(-):84595370,84595390,84626325,84626818 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.